WASHINGTON--(BUSINESS WIRE)--Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the confirmation of Alex Azar as United States Secretary of Health and Human Services (HHS):
“We look forward to working with Mr. Azar as he tackles the many pressing issues within the American health care system. I am confident that American patients will be well served by his leadership and I congratulate him on his confirmation.
“The opportunities facing HHS today are enormous. From encouraging the development of new technologies to help solve the opioid crisis and removing barriers to value-based payment models, to overseeing the FDA and NIH as they implement landmark new legislation to speed the science and development of new cures and promote greater competition and choice in the marketplace, the decisions made at HHS today will leave a lasting imprint on American health care for decades to come.”
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
|
Upcoming BIO Events |
|||
|
BIO
CEO & Investor Conference
BIO
Asia International Conference
March 19-20, 2018 Tokyo, Japan |
BIO
International Convention Boston, MA |
||
